Fas ligand-mediated apoptosis in degenerative disorders of the brain.
- 1 January 2003
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of Clinical Immunology
- Vol. 23 (5), 363-370
- https://doi.org/10.1023/a:1025317516396
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Putative function of ADAM9, ADAM10, and ADAM17 as APP -secretaseBiochemical and Biophysical Research Communications, 2003
- Metalloproteinase Shedding of Fas Ligand Regulates β-Amyloid NeurotoxicityCurrent Biology, 2002
- TNF-α and IFN-γ render microglia sensitive to Fas ligand-induced apoptosis by induction of Fas expression and down-regulation of Bcl-2 and Bcl-xLEuropean Journal of Immunology, 1998
- CD95-Induced Apoptosis of Lymphocytes in an Immune Privileged Site Induces Immunological ToleranceImmunity, 1996
- Selective activation of Fas/Fas ligand-mediated cytotoxicity by a self peptide.The Journal of Experimental Medicine, 1996
- Animal models of human disease Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating diseaseClinical Immunology and Immunopathology, 1995
- Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790Inflammation Research, 1995
- Fas(CD95)/FasL interactions required for programmed cell death after T-cell activationNature, 1995
- Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomasNature, 1995
- Fas and Fas ligand: lpr and gld mutationsImmunology Today, 1995